πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10669242

Clostridium difficile toxin inhibitors

VENENUM BIODESIGN, LLC Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668049

Methods of treating cognitive decline with transforming growth factor beta inhibitors

The Regents of the University of California Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662160

Crystalline salts of a plasma kallikrein inhibitor

BioCryst Pharmaceuticals, Inc. Β· Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662183

Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10646577

mTORC1 inhibitors

The Regents of the University of California Β· Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10647711

Azepin-2-one derivatives as RSV inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10647715

KRas G12C inhibitors

Mirati Therapeutics, Inc. Β· Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10646475

SHMT inhibitors

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10640493

Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treat

The Regents of the University of California Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10639289

Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial

CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10640501

Methods of preparing inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10639302

Use of CDK9 inhibitors to reduce cartilage degradation

The Regents of the University of California Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10640517

Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

Aurigene Discovery Technologies Limited Β· Granted Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633370

Phenyl indole allosteric inhibitors of p97 ATPase

The Regents of the University of California Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633381

KRas G12C inhibitors

Mirati Therapeutics, Inc. Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633345

Human plasma kallikrein inhibitors

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10632209

ASH1L inhibitors and methods of treatment therewith

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626094

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626087

Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the sa

The Board of Regents of the University of Texas System Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10626129

Heteroaryl inhibitors of PDE4

Tetra Discovery Partners Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10617737

Compositions for treating heart disease by inhibiting the action of mAKAP-Ξ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10610563

Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neur

BIOXCEL CORPORATION Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10611760

Therapeutic compounds as inhibitors of the orexin-1 receptor

C4X Discovery Limited Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10611758

N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors

KalVista Pharmaceuticals Limited Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted